Spontaneous regression of occult breast cancer with axillary lymph node metastasis: A case report. 2019

Shin Takayama, and Kaishi Satomi, and Masayuki Yoshida, and Chikashi Watase, and Takeshi Murata, and Sho Shiino, and Kenjiro Jimbo, and Akihiko Suto
National Cancer Center Hospital, Breast Surgery Division, 5-1-1, Tsukiji, Chuo-ku, Tokyo 104-0045, Japan. Electronic address: stakayam@ncc.go.jp.

BACKGROUND Spontaneous regression of a malignant tumor is defined as "the partial or complete disappearance of a malignant tumor in the absence of any treatment." Herein, we report a case of occult breast cancer with axillary lymph node metastasis that showed spontaneous tumor regression based on the histopathological findings. METHODS A 67-year-old woman presented with left armpit pain and a lump. Previous examination by another doctor revealed swelling of the left axillary lymph node, but it was difficult to identify the primary lesion. Needle biopsy of the left axillary lymph node revealed malignant tumor tissue with extensive necrosis on histological examination. On initial examination at our hospital, the left axillary lymph node was observed to have shrunk compared to previous observations. Moreover, findings indicated a suspected concentrated cyst in the left breast, with slight contrast enhancement on magnetic resonance imaging. Considering a diagnosis of occult breast cancer with axillary lymph node metastasis, excisional biopsy was performed for the left breast mass and axillary lymph node dissection for left axillary lymph node metastasis. Histological examination revealed a micro adenocarcinoma with lymphocyte infiltration in the left breast, and the viable tumor in the left axillary lymph node had disappeared. The histopathological findings of the primary tumor and dissected lymph nodes suggested the possibility of spontaneous regression of both the primary and metastatic lesions, because effective preoperative therapy was not performed.

UI MeSH Term Description Entries

Related Publications

Shin Takayama, and Kaishi Satomi, and Masayuki Yoshida, and Chikashi Watase, and Takeshi Murata, and Sho Shiino, and Kenjiro Jimbo, and Akihiko Suto
January 2014, International journal of clinical and experimental pathology,
Shin Takayama, and Kaishi Satomi, and Masayuki Yoshida, and Chikashi Watase, and Takeshi Murata, and Sho Shiino, and Kenjiro Jimbo, and Akihiko Suto
November 2017, Zhonghua bing li xue za zhi = Chinese journal of pathology,
Shin Takayama, and Kaishi Satomi, and Masayuki Yoshida, and Chikashi Watase, and Takeshi Murata, and Sho Shiino, and Kenjiro Jimbo, and Akihiko Suto
June 1981, Cancer,
Shin Takayama, and Kaishi Satomi, and Masayuki Yoshida, and Chikashi Watase, and Takeshi Murata, and Sho Shiino, and Kenjiro Jimbo, and Akihiko Suto
December 2021, Gan to kagaku ryoho. Cancer & chemotherapy,
Shin Takayama, and Kaishi Satomi, and Masayuki Yoshida, and Chikashi Watase, and Takeshi Murata, and Sho Shiino, and Kenjiro Jimbo, and Akihiko Suto
December 2018, Medicine,
Shin Takayama, and Kaishi Satomi, and Masayuki Yoshida, and Chikashi Watase, and Takeshi Murata, and Sho Shiino, and Kenjiro Jimbo, and Akihiko Suto
May 2023, Cureus,
Shin Takayama, and Kaishi Satomi, and Masayuki Yoshida, and Chikashi Watase, and Takeshi Murata, and Sho Shiino, and Kenjiro Jimbo, and Akihiko Suto
April 2024, Asian journal of surgery,
Shin Takayama, and Kaishi Satomi, and Masayuki Yoshida, and Chikashi Watase, and Takeshi Murata, and Sho Shiino, and Kenjiro Jimbo, and Akihiko Suto
September 2012, Journal of breast cancer,
Shin Takayama, and Kaishi Satomi, and Masayuki Yoshida, and Chikashi Watase, and Takeshi Murata, and Sho Shiino, and Kenjiro Jimbo, and Akihiko Suto
August 2020, The American journal of case reports,
Shin Takayama, and Kaishi Satomi, and Masayuki Yoshida, and Chikashi Watase, and Takeshi Murata, and Sho Shiino, and Kenjiro Jimbo, and Akihiko Suto
March 2022, International journal of surgery case reports,
Copied contents to your clipboard!